The global market for Tissue Engineering and Regeneration was valued at USD 23.7 billion in 2022 and is expected to grow to USD 98.5 billion by 2032 at a CAGR of 14.3%. The growth in the market is being driven by the rising incidence of chronic diseases such as diabetes, cancer, and cardiovascular diseases, which require tissue regeneration therapies.
The rise in the elderly population,...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian